Axol provides human iPSCs and has over 60 lines from healthy and diseased patients for neuronal disease modelling and cardiotoxicity testing. We also provide reprogramming, gene editing and differentiation services for all your iPSC research needs.
Axol is a leading provider of product and service solutions in the iPSC-based neuroscience, immune cell, and cardiac modeling for research, drug discovery and screening markets. Our custom research capabilities in gene editing, electrophysiology, reprogramming and differentiation means we can offer customers validated ready-to-use cell lines and a suite of services bolstered by deep scientific expertise and robust functional data - all with shorter lead times. Axol has over 60 lines from healthy and diseased patients for neuronal disease modelling and cardiotoxicity testing. All our products are manufactured under stringent ISO 9001 quality measures and each one undergoes at least 7 quality control tests before release. We believe in setting a new industry standard for quality and performance consistency of ready to use iPSC-derived cells, media products and related services, solidifying Axol Bioscience as the supplier of choice in the iPSC market.
Brands: Axol offers neural stem cells, motor and sensory neurons, astrocytes, microglia and both ventricular and atrial cardiomyocytes. We also offer isogenic controls and can differentiate our own or customer’s iPSCs cells into any cell type of choice.